UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

The role of interleukin‐12 on modulating myeloid‐derived suppressor cells, increasing overall survival and reducing metastasis

Immunology, 2011-06, Vol.133 (2), p.221-238

2011

Volltextzugriff (PDF)

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status

Cancer, 2004-07, Vol.101 (1), p.83-89

2004

Volltextzugriff (PDF)

The role of mitogen-activated protein (MAP) kinase in breast cancer

The Journal of steroid biochemistry and molecular biology, 2002-02, Vol.80 (2), p.239-256

2002

Volltextzugriff (PDF)

Glycomic profiling of invasive and non-invasive breast cancer cells

Glycoconjugate journal, 2009-02, Vol.26 (2), p.117-131

2009

Volltextzugriff (PDF)

HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (24), p.9185-9192

2004

Volltextzugriff (PDF)

Imatinib Mesylate (Gleevec) Inhibits Ovarian Cancer Cell Growth through a Mechanism Dependent on Platelet-Derived Growth Factor Receptor α and Akt Inactivation

Clinical cancer research, 2004-01, Vol.10 (2), p.681-690

2004

Volltextzugriff (PDF)

PDGF BB induces VEGF secretion in ovarian cancer

Cancer biology & therapy, 2007-12, Vol.6 (12), p.1951-1959

2007

Volltextzugriff (PDF)

Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy

Clinical cancer research, 2008-01, Vol.14 (1), p.291-299

2008

Volltextzugriff (PDF)

Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

The journal of gene medicine, 2010-06, Vol.12 (6), p.516-527

2010

Volltextzugriff (PDF)

Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy

Clinical cancer research, 2007-09, Vol.13 (18), p.5463-5473

2007

Volltextzugriff (PDF)

Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers

Molecular therapy, 2002-09, Vol.6 (3), p.415-421

2002

Volltextzugriff (PDF)

Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells

Breast cancer research and treatment, 2000-08, Vol.62 (3), p.167-175

2000

Volltextzugriff (PDF)

Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system

Cancer informatics, 2014-01, Vol.2014 (13), p.21-45

2014

Volltextzugriff (PDF)

Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis

The journal of gene medicine, 2006-06, Vol.8 (6), p.679-689

2006

Volltextzugriff (PDF)

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene

Molecular cancer therapeutics, 2006-03, Vol.5 (3), p.676-684

2006

Volltextzugriff (PDF)

Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by α-lactalbumin promoter

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.1850-1859

2005

Volltextzugriff (PDF)

Segregation of Steroid Receptor Coactivator-1 from Steroid Receptors in Mammary Epithelium

Proceedings of the National Academy of Sciences - PNAS, 1999-01, Vol.96 (1), p.208-213

1999

Volltextzugriff (PDF)

HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.3046-3051

2004

Volltextzugriff (PDF)

Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation

Cancer research (Chicago, Ill.), 1992-12, Vol.52 (23), p.6539-6546

1992

Volltextzugriff (PDF)

EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity

Cancer research (Chicago, Ill.), 2003-06, Vol.63 (12), p.3425-3429

2003

Volltextzugriff (PDF)

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1941-1951

2005

Volltextzugriff (PDF)

Growth stimulation and differential regulation of transforming growth factor-β1 (TGFβ1), TGFβ2, and TGFβ3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells

Molecular endocrinology (Baltimore, Md.), 1991-08, Vol.5 (8), p.1120-1128

1991

Volltextzugriff (PDF)

Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients

Journal of steroid biochemistry and molecular biology, 2001-12, Vol.79 (1), p.115-125

2001

Volltextzugriff (PDF)

Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells

Endocrinology (Philadelphia), 1993-06, Vol.132 (6), p.2622-2630

1993

Volltextzugriff (PDF)

Correction to: Prognostic Features of Signal Transducer and Activator of Transcription 3 in an ER(+) Breast Cancer Model System

Cancer informatics, 2014-01, Vol.2014 (13), p.125-129

2014

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)
Dissertationen
(1)

Sprache

Englisch
(47)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of interleukin‐12 on modulating myeloid‐derived suppressor cells, increasing overall survival and reducing metastasis

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status

The role of mitogen-activated protein (MAP) kinase in breast cancer

Glycomic profiling of invasive and non-invasive breast cancer cells

HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling

Imatinib Mesylate (Gleevec) Inhibits Ovarian Cancer Cell Growth through a Mechanism Dependent on Platelet-Derived Growth Factor Receptor α and Akt Inactivation

PDGF BB induces VEGF secretion in ovarian cancer

Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy

Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy

Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers

Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells

Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system

Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene

Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by α-lactalbumin promoter

Segregation of Steroid Receptor Coactivator-1 from Steroid Receptors in Mammary Epithelium

HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4

Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation

EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer

Growth stimulation and differential regulation of transforming growth factor-β1 (TGFβ1), TGFβ2, and TGFβ3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells

Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients

Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells

Correction to: Prognostic Features of Signal Transducer and Activator of Transcription 3 in an ER(+) Breast Cancer Model System

Suchergebnisse filtern